Health In Tech, Inc. Class A Common Stock (HIT) is a publicly traded Technology sector company. As of September 30, 2026, HIT trades at $0.81 with a market cap of $55.76M and a P/E ratio of -11.60. HIT moved +19.65% today. Year to date, HIT is -53.10%; over the trailing twelve months it is -74.43%. Its 52-week range spans $0.51 to $7.59. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces HIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Health In Tech forecasts 2026 revenue about $33 million, roughly in line with 2025: Health In Tech forecast full-year 2026 revenue of about $33 million, roughly in line with 2025.
| Metric | Value |
|---|---|
| Price | $0.81 |
| Market Cap | $55.76M |
| P/E Ratio | -11.60 |
| EPS | $-0.07 |
| Dividend Yield | 0.38% |
| 52-Week High | $7.59 |
| 52-Week Low | $0.51 |
| Volume | 51.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.83M |
| Net Income | $-3.95M |
| Gross Margin | 53.93% |
2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.